Atlas Trials

Vitrectomy, Subretinal Tissue Plasminogen Activator (TPA) and Intravitreal Gas for Submacular Haemorrhage Secondary to Exudative (Wet) Age-related Macular Degeneration (TIGER).

Clinical trial NCT04663750 · RECRUITING

Trial details

NCT number
NCT04663750
Sponsor
King's College Hospital NHS Trust
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Eye DiseasesMacular Degeneration, WetSub-Macular Hemorrhage
Start date
2021-04-16
Primary completion
2028-12-01
Enrollment
210

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.